Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether fenofibrate effects the toleration, safety,
or efficacy biomarkers of CP-742,033, a drug being developed for the treatment of obesity.